Benchmark (LON:BMK) Reaches New 52-Week Low - Time to Sell?

Key Points

• Benchmark Holdings plc reached a new 52-week low, trading at GBX 16 ($0.22) before closing at GBX 20 ($0.27).
• The company reported a negative earnings per share (EPS) of GBX (1.77) ($0.02) for the last quarter, alongside a negative net margin of 43.67%.
• Benchmark's stock has a market capitalization of £148.25 million and very low price-to-earnings ratios, indicating significant financial challenges.

Benchmark Holdings plc (LON:BMK - Get Free Report) shares hit a new 52-week low on Monday . The company traded as low as GBX 16 ($0.22) and last traded at GBX 20 ($0.27), with a volume of 469706 shares. The stock had previously closed at GBX 19.50 ($0.26).

Benchmark Price Performance

The stock has a market capitalization of £148.25 million, a price-to-earnings ratio of -3.75, a price-to-earnings-growth ratio of -19.62 and a beta of 0.69. The company has a current ratio of 1.73, a quick ratio of 1.41 and a debt-to-equity ratio of 33.02. The stock has a 50-day simple moving average of GBX 23.57 and a 200 day simple moving average of GBX 23.95.

Benchmark (LON:BMK - Get Free Report) last announced its quarterly earnings results on Thursday, June 12th. The company reported GBX (1.77) (($0.02)) earnings per share (EPS) for the quarter. Benchmark had a negative net margin of 43.67% and a negative return on equity of 16.05%. On average, equities research analysts forecast that Benchmark Holdings plc will post 0.9566873 EPS for the current fiscal year.

Benchmark Company Profile

Benchmark's mission is to enable aquaculture producers to improve their sustainability and profitability.We bring together biology and technology to develop innovative products which improve yield, quality and animal health and welfare for our customers. We do this by improving the genetic make-up, health and nutrition of their stock - from broodstock and hatchery through to nursery and grow out. Benchmark has a broad portfolio of products and solutions, including salmon eggs, live feed (artemia), diets and probiotics and sea lice treatments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.